Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not ...
Apr 9, 2019
0
22
(HealthDay)—For people with hepatitis C virus (HCV) who inject drugs (PWID) and receive opioid agonist therapy (OAT), receipt of HCV treatment is associated with high sustained virologic response (SVR), according to a study ...
Apr 9, 2019
0
0
Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43 per cent globally, according to a study by researchers at the University of Bristol published ...
Apr 9, 2019
0
4
A new study reveals that rising rates of liver cancer deaths in the United States have largely been confined to individuals who have received less education, especially among men. Published early online in Cancer, a peer-reviewed ...
Apr 8, 2019
0
1
Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were able to engineer HBV-specific T cells, a type of immune cells found in the body, to treat Hepatocellular ...
Mar 28, 2019
0
3
One of the commonest causes of congenital disability, the Human Cytomegalovirus (HCMV), is less prone to mutation than previously thought, a finding which could help develop a successful vaccine, UCL researchers have found.
Feb 25, 2019
0
34
Nine patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a study published in the American ...
Feb 25, 2019
0
164
Researchers of the University of Barcelona (UB) have used massive sequencing techniques with samples from patients to determine the evolution of the hepatitis A virus. The results, published in the journal EBioMedicine, show ...
Feb 8, 2019
0
1
A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030—equal to an 80% reduction ...
Jan 29, 2019
0
1
(HealthDay)—Among deceased organ donors, there has been an increase in the proportion at increased risk for transmitting hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV to recipients, according to research published ...
Jan 25, 2019
0
0
